Axsome Thera (AXSM)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
03-2024 | 12-2023 | 09-2023 | 06-2023 | 03-2023 | |
Sales | 74,999 | 71,530 | 57,794 | 46,700 | 94,576 |
Cost of Goods | 6,297 | 7,378 | 6,532 | 4,599 | 7,556 |
Gross Profit | 68,702 | 64,152 | 51,262 | 42,101 | 87,020 |
Operating Expenses | 136,274 | 162,804 | 113,914 | 107,757 | 93,950 |
Operating Income | -67,275 | -98,274 | -62,120 | -65,057 | -6,374 |
Interest Expense | 1,082 | 702 | 757 | 2,730 | 2,264 |
Pre-tax Income | -68,357 | -98,976 | -62,877 | -67,787 | -8,638 |
Income Tax | N/A | -325 | -678 | -617 | 2,580 |
Net Income Continuous | -68,357 | -98,651 | -62,199 | -67,170 | -11,218 |
Net Income | $-68,357 | $-98,651 | $-62,199 | $-67,170 | $-11,218 |
EPS Basic Total Ops | -1.44 | -2.15 | -1.32 | -1.54 | -0.26 |
EPS Basic Continuous Ops | -1.44 | -2.15 | -1.32 | -1.54 | -0.26 |
EPS Diluted Total Ops | -1.44 | -2.15 | -1.32 | -1.54 | -0.26 |
EPS Diluted Continuous Ops | -1.44 | -2.15 | -1.32 | -1.54 | -0.26 |
EPS Diluted Before Non-Recurring Items | -1.09 | -0.73 | -1.32 | -1.00 | -0.22 |
EBITDA(a) | $-64,825 | $-96,080 | $-60,522 | $-61,687 | $-4,128 |